Transforming everyday health, one app at a time
Transforming everyday health, one app at a time unknown
Patients, even those with serious conditions, can be empowered to have
Exclusive: Huma receives US FDA Class II clearance for SaMD ...
Exclusive: Huma receives US FDA Class II clearance for SaMD ... unknown
Huma Therapeutics has received US Food and Drug Administration
US FDA grants 510(k) Class II regulatory clearance to Huma Therapeutics' configurable SaMD disease management platform
US FDA grants 510(k) Class II regulatory clearance to Huma Therapeutics' configurable SaMD disease management platform unknown
Huma
Huma receives FDA clearance for digital health platform
Huma receives FDA clearance for digital health platform unknown
Digital health company Huma Therapeutics has received Class II clearance from
Huma receives multi─condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform
Huma receives multi─condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform unknown
Huma Therapeutics
Huma acquires Alcedis to expand clinical trial platform
Huma acquires Alcedis to expand clinical trial platform unknown
Digital health tech company Huma acquired clinical trial data specialist Alcedis,